Preliminary data from clinical trials of tecovirimat as a treatment for mpox virus infection have given disappointing results ...

The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.

Nursing course applications in the UK have fallen 30% since 2021, prompting urgent calls for action to prevent further NHS ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

Biomarker panel based on capsule Cytosponge could simplify Barrett esophagus surveillance and reduce endoscopies in low-risk ...

Even in people without high blood pressure, subclinical primary aldosteronism is linked to a significantly higher risk for MACE, a new study finds.

Surgeon-performed transoral and transcervical ultrasound detected oropharyngeal tumours with 86% accuracy, outperforming MRI, ...

Compared with control women, those with PCOS may have increased psychological symptoms, including anxiety, depression, and ...

Influencers on social media tout the benefits of okra-infused water for glucose control. But experts are skeptical — at best.